GO:0090031 positive regulation of steroid hormone biosynthetic process: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090031 describes any process that increases the frequency, rate or extent of the chemical reactions and pathways that form steroid hormones, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus that act as hormones.
• Steroid hormone biosynthesis is positively regulated at multiple levels, including transcriptional control by nuclear receptors and coactivators, chromatin modification, and post-translational modulation of biosynthetic enzymes [2,3,8].
• Key regulatory nodes include steroid receptor coactivators, the GREB1-steroid receptor feedforward loop, KAT2B-mediated H3K27 acetylation, and Schlank-dependent chromatin switching in endocrine tissues [3,4,8].
• Dysregulation of positive regulation of steroid hormone biosynthesis contributes to endocrine-related diseases such as endometriosis, polycystic ovary syndrome, ovarian cancer endocrine resistance, and steroid-induced osteonecrosis [3,5,6,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of regulatory genes within this GO term, from receptor-coactivator interactions to enzyme hydroxylation steps [3,5,7,8].
• Studying GO:0090031 requires integrated approaches including chromatin immunoprecipitation, transcriptomics, metabolomics, and steroid profiling to link regulatory events to hormone output [3,4,7,8].
Description
GO:0090031, positive regulation of steroid hormone biosynthetic process, is a biological process ontology term that captures any mechanism which increases the frequency, rate, or extent of the chemical reactions and pathways leading to the formation of steroid hormones. Steroid hormones are compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus that function as signaling molecules in diverse physiological contexts, including reproduction, metabolism, and stress responses. The term is defined in QuickGO as any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones, compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones. Understanding this positive regulatory layer is essential because steroid hormone levels are tightly controlled, and their dysregulation underlies numerous endocrine pathologies [2,3,8]. Research into GO:0090031 spans transcriptional, epigenetic, and post-translational mechanisms. Nuclear receptors and their coactivators directly enhance the expression of steroidogenic enzymes, while chromatin-modifying enzymes such as KAT2B alter histone acetylation to promote estradiol synthesis. The GREB1-steroid receptor feedforward mechanism exemplifies how positive regulation can be self-reinforcing in endometrial function and endometriosis. In insects, Schlank coordinates developmental transitions by switching histone modifications in the prothoracic gland, highlighting evolutionary conservation of steroidogenic regulation. These examples illustrate that positive regulation of steroid hormone biosynthesis is not a single event but a network of interacting processes. For researchers, GO:0090031 provides a framework to annotate and investigate genes that enhance steroid hormone production. Experimental models ranging from knockout mice to CRISPR-engineered cell lines allow precise manipulation of candidate regulators [3,5,7,8]. This article synthesizes current knowledge on the mechanisms, key genes, disease relevance, and research methods associated with GO:0090031, with all factual claims supported by published literature.
positive regulation of steroid hormone biosynthetic process At A Glance
| GO ID | GO:0090031 |
|---|---|
| GO term | positive regulation of steroid hormone biosynthetic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the rate or extent of steroid hormone biosynthesis |
| Parent term | positive regulation of hormone biosynthetic process |
| Related processes | Steroid hormone biosynthesis, hormone metabolic process, regulation of steroid biosynthetic process |
| Cellular context | Endocrine tissues (ovary, testis, adrenal cortex, placenta), granulosa cells, prothoracic gland |
| Disease relevance | Endometriosis, polycystic ovary syndrome, ovarian cancer, osteonecrosis |
What Is GO:0090031?
In simple terms, GO:0090031 refers to any biological process that boosts the production of steroid hormones. The official QuickGO definition states: Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones, compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones. This term is a child of positive regulation of hormone biosynthetic process and is used to annotate gene products that enhance, rather than directly perform, steroid hormone synthesis. It encompasses transcriptional activation of steroidogenic enzymes, stabilization of biosynthetic machinery, and signaling cascades that amplify hormone output [2,3,8].
Why Is positive regulation of steroid hormone biosynthetic process Important in Cell Biology?
Positive regulation of steroid hormone biosynthesis is critical because steroid hormones control essential physiological processes such as reproduction, development, metabolism, and immune function. When this regulation goes awry, it can lead to diseases including endometriosis, polycystic ovary syndrome, endocrine-resistant cancers, and steroid-induced osteonecrosis [3,5,6,8]. Understanding the positive regulatory mechanisms provides targets for therapeutic intervention and biomarkers for diagnosis. Moreover, this GO term helps researchers systematically annotate genes that enhance steroidogenesis, facilitating comparative studies across species and disease models [2,4,7].
• Steroid hormones regulate reproduction, metabolism, and stress responses; their overproduction or underproduction causes endocrine disorders [2,3].
• Positive regulation of steroid hormone biosynthesis is often hijacked in hormone-dependent cancers, contributing to tumor growth and endocrine resistance.
• The GREB1-steroid receptor feedforward loop exemplifies how positive regulation can sustain pathological states like endometriosis.
• Chromatin-modifying enzymes such as KAT2B enhance estradiol synthesis, linking epigenetic regulation to steroidogenic output in PCOS.
• Insect developmental transitions depend on Schlank-mediated chromatin switching in the prothoracic gland, showing conserved regulatory logic.
• Vitamin D hydroxylation in the proximal tubule is positively regulated to maintain calcium homeostasis, illustrating systemic importance.
• Inhibition of protein disulfide isomerase reduces oxidative stress and osteoclast activity in steroid-induced osteonecrosis, highlighting therapeutic potential.
• CRISPR screens can identify novel positive regulators of steroidogenesis, accelerating target discovery [3,5,8].
• Understanding positive regulation aids in designing drugs that modulate hormone levels without ablating essential functions [2,5].
• This GO term supports functional annotation of genomes and transcriptomes in endocrine research [3,4,7].
What Happens During positive regulation of steroid hormone biosynthetic process?
Transcriptional activation of steroidogenic enzymes
In simple terms: This step turns on the genes that make the enzymes needed to build steroid hormones.
Positive regulation often begins with transcription factors and nuclear receptors binding to promoter regions of steroidogenic enzyme genes, increasing their expression. For example, steroid hormone regulation of nuclear proto-oncogenes demonstrates early transcriptional responses to hormonal signals. In granulosa cells, KAT2B regulates estradiol synthesis via H3K27ac and PPARα, directly linking chromatin modification to transcriptional activation of steroidogenic genes. The GREB1-steroid receptor feedforward mechanism further amplifies transcriptional output in endometrial cells.
Epigenetic remodeling and chromatin accessibility
In simple terms: This step changes how DNA is packaged so that steroid-making genes can be read more easily.
Chromatin modifications such as histone acetylation and methylation alter access to steroidogenic gene loci. Schlank orchestrates insect developmental transition by switching H3K27 acetylation to trimethylation in the prothoracic gland, thereby regulating steroid hormone production. In mammalian cells, KAT2B-mediated H3K27ac promotes estradiol synthesis, showing that epigenetic writers can act as positive regulators. These modifications create a permissive state for transcription of biosynthetic enzymes.
Post-translational modulation of biosynthetic enzymes
In simple terms: This step adjusts the activity of enzymes already made, without changing gene expression.
Beyond transcription, positive regulation can occur through post-translational modifications or protein-protein interactions that enhance enzyme activity. For instance, inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis by suppressing osteoclast activity through reduction of cellular oxidative stress, indicating that redox regulation intersects with steroidogenic pathways. Vitamin D hydroxylation in the proximal tubule is regulated to maintain active hormone levels, involving enzymatic steps that can be positively modulated.
Feedforward amplification loops
In simple terms: This step creates a cycle where the product of a pathway stimulates its own production.
The GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis, where GREB1 enhances steroid receptor activity, which in turn increases GREB1 expression and steroidogenesis. Such loops can sustain high hormone output and are often dysregulated in disease. Mutant p53 can bind and control estrogen receptor activity to drive endocrine resistance in ovarian cancer, illustrating another layer of positive regulation.
Key Genes Involved in GO:0090031 positive regulation of steroid hormone biosynthetic process
The following genes and proteins are experimentally implicated in positive regulation of steroid hormone biosynthetic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GREB1 | Enhances steroid receptor activity in a feedforward loop | Implicated in endometriosis and endometrial function |
| ESR1 | Estrogen receptor that activates steroidogenic gene transcription | Central to endocrine resistance in ovarian cancer |
| KAT2B | Histone acetyltransferase that deposits H3K27ac at steroidogenic loci | Regulates estradiol synthesis in PCOS granulosa cells |
| PPARα | Nuclear receptor cooperating with KAT2B to promote estradiol synthesis | Linked to PCOS pathology |
| Schlank | Chromatin modifier switching H3K27 acetylation to trimethylation | Controls insect developmental transition via prothoracic gland |
| TP53 | Mutant p53 binds estrogen receptor to drive endocrine resistance | Ovarian cancer endocrine resistance |
| PDI | Protein disulfide isomerase modulates oxidative stress in osteoclasts | Steroid-induced osteonecrosis |
| CYP27B1 | 1α-hydroxylase activating vitamin D | Regulated in proximal tubule for calcium homeostasis |
| CYP24A1 | 24-hydroxylase inactivating vitamin D | Regulated in proximal tubule |
| Nuclear proto-oncogenes (e.g., c-Myc, c-Fos) | Early transcriptional responders to steroid hormones | Steroid hormone regulation of gene expression |
| Steroid receptor coactivators | Enhance nuclear receptor-mediated transcription | General positive regulators of steroidogenesis [2,3] |
| H3K27ac readers | Interpret histone acetylation marks | Epigenetic regulation of steroidogenic genes [4,8] |
| H3K27me3 writers | Deposit repressive methylation marks | Switch from acetylation to methylation in prothoracic gland |
| Oxidative stress response proteins | Modulate cellular redox state | Influence osteoclast activity in osteonecrosis |
| Vitamin D receptor | Mediates vitamin D signaling | Regulates hydroxylase expression in kidney |
| Steroidogenic acute regulatory protein (StAR) | Facilitates cholesterol transport | Rate-limiting for steroidogenesis, indirectly regulated |
| Cytochrome P450 enzymes | Catalyze steroid hormone biosynthesis steps | Targets of positive regulation [2,7] |
How Is positive regulation of steroid hormone biosynthetic process Regulated?
Positive regulation of steroid hormone biosynthetic process is itself regulated at multiple levels. Transcriptional control involves nuclear receptors and their coactivators, as seen with steroid hormone regulation of nuclear proto-oncogenes. Epigenetic regulation through histone acetylation and methylation, exemplified by KAT2B and Schlank, provides another layer [4,8]. Feedforward loops such as the GREB1-steroid receptor mechanism can amplify and sustain steroidogenic output. Additionally, post-translational modifications and redox balance influence enzyme activity, as observed with protein disulfide isomerase in osteonecrosis. Vitamin D hydroxylation is regulated to maintain systemic calcium homeostasis, showing endocrine feedback. Mutant p53 can aberrantly enhance estrogen receptor activity, linking oncogenic signaling to steroidogenesis.
positive regulation of steroid hormone biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GREB1 | Endometriosis | Knockout or knockdown in endometrial cell lines; mouse xenograft |
| KAT2B | Polycystic ovary syndrome | Granulosa cell overexpression or knockout; PCOS mouse model |
| TP53 (mutant) | Ovarian cancer endocrine resistance | Knock-in of mutant p53 in ovarian cancer cells; xenograft |
| PDI | Steroid-induced osteonecrosis | Knockout or inhibitor treatment in osteoclast cultures; rabbit model |
| CYP27B1/CYP24A1 | Vitamin D-related disorders | Knockout mice; proximal tubule cell lines |
Endometriosis and endometrial dysfunction
The GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis, where positive regulation of steroid hormone biosynthesis contributes to lesion growth and pain. Targeting this loop may offer therapeutic benefit.
Polycystic ovary syndrome (PCOS)
KAT2B regulates estradiol synthesis via H3K27ac/PPARα in granulosa cells of PCOS patients, linking epigenetic positive regulation to hyperandrogenism and ovulatory dysfunction. This pathway represents a potential target for PCOS management.
Ovarian cancer and endocrine resistance
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer, illustrating how positive regulation of steroid hormone biosynthesis can promote tumor survival and therapy escape. Inhibiting this interaction may restore sensitivity to endocrine therapy.
Steroid-induced osteonecrosis of the femoral head
Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis by suppressing osteoclast activity through reduction of cellular oxidative stress, highlighting the role of redox regulation in steroid-related bone pathology. Modulating positive regulation of steroidogenesis may reduce osteonecrosis risk.
From positive regulation of steroid hormone biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GREB1 reduce steroid hormone biosynthesis? | GREB1 knockout in endometrial cells or mice |
| Does KAT2B overexpression increase estradiol synthesis? | KAT2B overexpression in granulosa cells |
| Does mutant p53 enhance estrogen receptor activity? | Point mutation knock-in of TP53 in ovarian cancer cells |
| Does PDI inhibition alter osteoclast activity? | PDI knockout or pharmacological inhibition in osteoclasts |
| How does Schlank chromatin switching affect steroidogenesis? | Schlank knockout or tagged knock-in in insect prothoracic gland |
| Does vitamin D receptor regulate hydroxylase expression? | VDR knockout in proximal tubule cells |
How to Study the positive regulation of steroid hormone biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify steroidogenic enzymes upregulated by positive regulators [3,8] |
| ChIP-seq | Histone modification and transcription factor occupancy | Map H3K27ac at steroidogenic loci [4,8] |
| Mass spectrometry | Steroid hormone levels | Quantify estradiol, cortisol, vitamin D metabolites |
| CRISPR knockout | Loss-of-function effects | Test necessity of candidate regulators [3,5] |
| CRISPR knock-in | Precise mutation or tag insertion | Model point mutations or track proteins |
| Overexpression | Gain-of-function effects | Test sufficiency of regulators |
| Immunoassay | Specific hormone concentrations | Measure steroid output in cell culture or serum [6,7] |
| Proteomics | Protein abundance and interactions | Identify coactivator complexes [2,3] |
Transcriptomic profiling
RNA-seq can identify genes whose expression changes upon manipulation of candidate positive regulators, revealing steroidogenic enzyme induction. For example, KAT2B-dependent estradiol synthesis was linked to H3K27ac and PPARα target genes. GREB1 feedforward mechanisms were dissected using transcriptomic approaches.
Epigenomic mapping
ChIP-seq for histone modifications such as H3K27ac and H3K27me3 can map regulatory elements at steroidogenic gene loci. Schlank-mediated switching from H3K27 acetylation to trimethylation was demonstrated using such methods. KAT2B occupancy at steroidogenic promoters was also assessed.
Steroid hormone quantification
Mass spectrometry or immunoassays measure hormone levels (e.g., estradiol, cortisol, vitamin D metabolites) to directly assess biosynthetic output. Vitamin D hydroxylation studies used such measurements in proximal tubule models. Osteonecrosis studies quantified steroid-induced effects.
CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of candidate regulators. Mutant p53 knock-in revealed its role in estrogen receptor control. GREB1 knockout clarified its feedforward function.
How CRISPR Can Be Used to Study GO:0090031 positive regulation of steroid hormone biosynthetic process
Knockout
CRISPR knockout of candidate positive regulators (e.g., GREB1, KAT2B) can determine whether they are required for steroid hormone biosynthesis. GREB1 knockout in endometrial cells disrupted feedforward regulation. KAT2B knockout reduced estradiol synthesis in granulosa cells.
Point Mutation
Point mutation knock-in can model specific amino acid changes in regulators, such as mutant p53 that binds estrogen receptor. This approach revealed how mutant p53 drives endocrine resistance in ovarian cancer. Point mutations in steroidogenic enzymes can also alter catalytic activity.
Knock-in
Knock-in of tags (e.g., GFP, HA) allows tracking of regulator localization and interactions. Tagged Schlank knock-in would enable visualization of chromatin switching in the prothoracic gland. Knock-in of reporter genes can monitor steroidogenic promoter activity.
Overexpression
CRISPR activation or cDNA overexpression can test sufficiency of positive regulators. Overexpression of KAT2B increased estradiol synthesis via H3K27ac/PPARα. Overexpression of GREB1 enhanced steroid receptor activity.
How EDITGENE Supports positive regulation of steroid hormone biosynthetic process Research
Researchers studying positive regulation of steroid hormone biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in enhancing hormone production. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling precise functional dissection of GO:0090031 regulators.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of steroid hormone biosynthetic process research.
Frequently Asked Questions About positive regulation of steroid hormone biosynthetic process
What is GO:0090031?
GO:0090031 is the Gene Ontology term for positive regulation of steroid hormone biosynthetic process, defined as any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones [2,3].
What genes are involved in positive regulation of steroid hormone biosynthetic process?
Key genes include GREB1, ESR1, KAT2B, PPARα, TP53, and chromatin modifiers like Schlank, as well as steroidogenic enzymes such as CYP27B1 and CYP24A1 [3,4,5,7,8].
How is steroid hormone biosynthesis positively regulated?
It is regulated through transcriptional activation by nuclear receptors and coactivators, epigenetic remodeling, feedforward loops, and post-translational modulation of enzymes [2,3,4,8].
What diseases are linked to dysregulated positive regulation of steroid hormone biosynthesis?
Diseases include endometriosis, polycystic ovary syndrome, ovarian cancer endocrine resistance, and steroid-induced osteonecrosis [3,5,6,8].
What is the role of GREB1 in steroid hormone biosynthesis?
GREB1 participates in a feedforward mechanism with steroid receptors to enhance endometrial function, and its dysregulation is implicated in endometriosis.
How does KAT2B regulate estradiol synthesis?
KAT2B deposits H3K27ac at steroidogenic gene loci and cooperates with PPARα to promote estradiol synthesis in granulosa cells, with relevance to PCOS.
Can CRISPR be used to study positive regulation of steroid hormone biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators in this pathway [3,5,7,8].
What methods measure steroid hormone biosynthesis?
Methods include mass spectrometry, immunoassays, RNA-seq, ChIP-seq, and proteomics to quantify hormones and map regulatory events [3,4,7,8].
What is the role of mutant p53 in steroid hormone regulation?
Mutant p53 can bind and control estrogen receptor activity, driving endocrine resistance in ovarian cancer.
How does protein disulfide isomerase relate to steroid-induced osteonecrosis?
Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis by suppressing osteoclast activity through reduction of oxidative stress.
Conclusion
GO:0090031, positive regulation of steroid hormone biosynthetic process, encompasses diverse mechanisms that enhance the production of steroid hormones, from transcriptional and epigenetic control to feedforward loops and post-translational modulation. Dysregulation of these processes contributes to major endocrine pathologies, including endometriosis, PCOS, ovarian cancer, and osteonecrosis. CRISPR-based models and integrated omics approaches are powerful tools to dissect these regulatory networks. EDITGENE provides end-to-end services to support such research, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 2. Schuchard M et al.. 1993. Steroid hormone regulation of nuclear proto-oncogenes.. Endocr Rev 14(6):659-69 PMID: 8119231
- 3. Chadchan SB et al.. 2024. A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis.. Nat Commun 15(1):1947 PMID: 38431630
- 4. Yuan D et al.. 2024. Schlank orchestrates insect developmental transition by switching H3K27 acetylation to trimethylation in the prothoracic gland.. Proc Natl Acad Sci U S A 121(35):e2401861121 PMID: 39167603
- 5. Shao C et al.. 2026. Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer.. Genes Dev 40(3-4):199-214 PMID: 41193244
- 6. Zhang X et al.. 2024. Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress.. Chem Biol Interact 404:111263 PMID: 39393751
- 7. Young K et al.. 2022. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule.. Exp Biol Med (Maywood) 247(13):1103-1111 PMID: 35482362
- 8. Wang A et al.. 2025. KAT2B regulates estradiol synthesis via H3K27ac/PPARα in granulosa cells of PCOS patients.. J Transl Med 23(1):833 PMID: 40713779
